Adore Beauty (ABY)
ABY $0.25
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Share price activity
- Last (Price)
- 0.25
- Change
- 0.00 (0.00)
- Bid / Ask
- 0.25 - 0.25
- Volume
- 580
- Turnover
- 143
- Open
- 0.25
- Day Range
- 0.25 - 0.25
- VWAP
- 0.25
- Prev Close
- 0.25
- Last Trade
- 11/11 1:39pm
Key information
- Sector
- Consumer Cyclical
- Shares Issued
- 93,957,928
- NTA/Share
- 0.08
- Last Dividend
- —
- Dividend Ex Date
- —
- Dividend Pay Date
- —
Current (AUD) · FY2026
- Revenue
- 207.28
- EBITDA
- 4.69
- Profit
- -4.38
- Earnings Per Share (EPS)
- -0.05
- Dividend Per Share (DPS)
- —
- Yield %
- 0.00
- Market Cap
- 23.02
- Price to Earnings Ratio (P/E)
- -5.26
Estimates (AUD)
No consensus estimates are available for this company.
Quantitative rating
Undervalued
- Economic Moat
- None
- Financial Health
- Weak
- Uncertainty
- Very High
Morningstar Quantitative Rating as of 6 NOV 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Five-star price 0.24 Fair value 0.40 One-star price 0.69
Morningstar Quantitative Rating as of 6 NOV 2026.
Quantitative valuation
- Fair Value
- 0.40
- Price / Fair Value
- 0.66
- Valuation
- Undervalued
- Uncertainty
- Very High
Morningstar Quantitative Rating as of 6 NOV 2026. The slider runs from the five-star price (0.24) to the one-star price (0.69).
| Ratios |
|---|
| Currency (Price/reporting): AUD/AUD |
| Exchange Rate: 1.0000 |
| Price - closing or last bid | 0.27 |
| Price - 12 month high | 1.33 |
| Price - 12 month low | 0.23 |
| Pricing date | 6 NOV 2026 |
| Volume - avg. trading volume for the last ten days | 0.03 |
| Market capitalization | 24.90 |
| 12 Month High price date | 8 DEC 2025 |
| 12 Month Low price date | 7 AUG 2026 |
| Volume - avg. trading volume for the last 3 months | 0.14 |
| Price - 1 Day % Change | 0.00% |
| Price - 13 week price percent change | 8.16% |
| Price - 26 week price percent change | -32.05% |
| Price - 5 Day % Change | 6.00% |
| Price - 52 week price percent change | -77.92% |
| Price - YTD price percent change | -79.13% |
| Price % Change Month To Date | -8.62% |
| EPS excluding extraordinary items - most recent fiscal year | -0.047 |
| EPS excluding extraordinary items - trailing 12 month | -0.047 |
| EPS Normalized - most recent fiscal year | -0.037 |
| Revenue/share - most recent fiscal year | 2.206 |
| Revenue/share - trailing 12 month | 2.206 |
| Book value per share - most recent fiscal year | 0.383 |
| Book value per share - most recent half-year | 0.383 |
| Book value (tangible) per share - most recent fiscal year | 0.078 |
| Book value (tangible) per share - most recent half-year | 0.078 |
| Cash per share - most recent fiscal year | 0.008 |
| Cash per share - most recent half-year | 0.008 |
| Cash Flow per share - most recent fiscal year | -0.022 |
| Cash Flow per share - trailing 12 month | -0.022 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.000 |
| EBITD per share - trailing 12 month | 0.050 |
| EPS Basic excluding extraordinary items - most recent fiscal year | -0.047 |
| EPS Basic excluding extraordinary items - trailing 12 month | -0.047 |
| EPS including extraordinary items - most recent fiscal year | -0.047 |
| EPS including extraordinary items - trailing 12 month | -0.047 |
| Free Cash Flow per share - trailing 12 month | -0.206 |
| P/E excluding extraordinary items, most recent fiscal year | — |
| P/E Normalized, most recent fiscal year | — |
| Price to sales - most recent fiscal year | 0.12 |
| Price to Tangible Book - most fiscal year | 3.39 |
| Price to Free Cash Flow per Share - most recent fiscal year | — |
| Price to Cash Flow per share - trailing 12 month | — |
| Price to Book - most recent fiscal year | 0.69 |
| P/E excluding extraordinary items high, trailing 12 months | 182.35 |
| P/E excluding extraordinary items low, trailing 12 months | 70.59 |
| Net Debt, LFI | 20.09 |
| Net Debt, LFY | 42.87 |
| Dividend Yield - 5 Year Average | — |
| Dividend Yield - indicated annual dividend divided by closing price | — |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 0.00% |
| Free Cash Flow - most recent fiscal year | -19.37 |
| LT debt/equity - most recent fiscal year | 88.64% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 121.01% |
| LT debt/equity - most recent half-year | 50.55% |
| Total debt/total equity - most recent half-year | 69.50% |
| Free Cash Flow - trailing 12 month | -19.37 |
| Payout ratio - trailing 12 month | — |
| Revenue - most recent fiscal year | 207.28 |
| Revenue - trailing 12 month | 207.28 |
| EBITD - most recent fiscal year | 4.69 |
| EBITD - trailing 12 month | 4.69 |
| Earnings before taxes - most recent fiscal year | -6.06 |
| Earnings before taxes - trailing 12 month | -6.06 |
| Net Income available to common - most recent fiscal year | -4.38 |
| Net Income available to common - trailing 12 months | -4.38 |
| Earnings before taxes Normalized - most recent fiscal year | -4.87 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | -0.04 |
| Net Profit Margin % - 1st historical fiscal year | -2.11% |
| Net Profit Margin % - trailing 12 month | -2.11% |
| Operating margin - 1st historical fiscal year | -1.58% |
| Operating margin - trailing 12 month | -1.58% |
| Pretax margin - trailing 12 month | -2.92% |
| Pretax margin - 1st historical fiscal year | -2.92% |
| Operating Margin - 5 year average | 0.54% |
| Pretax Margin - 5 year average | 0.00% |
| Free Operating Cash Flow/Revenue, 5 Year Average | -0.01% |
| Free Operating Cash Flow/Revenue, TTM | -9.35% |
| Net Profit Margin - 5 year average | 0.05% |
| Return on average assets - most recent fiscal year | -4.31% |
| Return on average assets - trailing 12 month | -4.31% |
| Return on average equity - most recent fiscal year | -11.23% |
| Return on average equity - trailing 12 month | -11.23% |
| Return on average assets - 5 year average | 0.77% |
| Return on average equity - 5 year average | 1.00% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
| Revenue growth rate, 5 year | 2.95% |
| EPS growth rate, 5 year | — |
| Growth rate% - dividend, 3 year | — |
| Revenue/share (5 yr growth) | 2.49% |
| Growth rate% - Revenue, 3 year | 4.70% |
| Growth rate% - EPS, 3 year | — |
| Book value per share growth rate, 5 year | 1.04% |
| Capital Spending growth rate, 5 year | 54.07% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 23.21% |
Financial forecast (AUD, millions except per share)
No consensus estimates are available for this company.
Financials (AUD, millions)
| Period end: | JUN 22 | JUN 23 | JUN 24 | JUN 25 | JUN 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
Opinion
Emerging Companies Portfolio
The portfolio was up +7.72% in the week, outperforming the S&P/ASX Small Ords index which rallied +4.06%. Cash in the portfolio fell to around 5% after we added Sandfire Resources (SFR) to the portfolio. The Copper miner was one of the standout performers in the week, rallying 16% since our purchase. Also supporting the outperformance was a 19% rally in lithium miner...
Adore Beauty (ABY) $1.645
ABY -10.60%: the beauty products e-commerce business reported disappointing numbers and a softer outlook, weighing on the stock today. Revenue was a small miss to expectations despite being up +65% for the year, coming in at $199.7m. EBITDA at $5.3m was marginally below the consensus estimate as well, though EBTIDA margins were in line. FY23 expectations...
Emerging Companies Portfolio
The portfolio was down -6.31% in the week, underperforming the small ords. Cash in the portfolio is sitting at around 9% while the portfolio is now up 13.10% for the financial year to date. This week the losers were last week’s winners, Adore Beauty (ABY) -21.36%, having been up 50% the week before, while Audinate (AD8) fell -12.45% following their FY22 results. Pilbara Minerals (PLS) +3.15%, unfortunately, was the only stock to make a positive contribution to performance.
Adore Beauty (ABY) $2.20
The online beauty products retailer rallied yesterday and shares are now more than double the June lows despite CEO Tennealle O’Shannessy announcing her resignation last week (moving to IDP Education). The stock added to the rally yesterday, jumping 30% on the back of a strong result from eCommerce peer Temple & Webster (TPW). While not playing...
Emerging Companies Portfolio
The portfolio was up +1.62% in the week, outpacing the performance of the small ords. Cash in the portfolio is sitting at around 9%. The portfolio is now up 20.10% for the financial year to date, a strong outperformance to its benchmark. This week the winners were led by Adore Beauty (ABY) climbing over 50%, while Strandline (STA) rose ~11% and Capitol Health (CAJ) was up ~8.5%. The main detractor was St Barbara (SBM), falling -14% on disappointing guidance.
Emerging Companies Portfolio
The portfolio was up +4.10% in the week while cash s sitting at around 9%. For the month of July the portfolio enjoyed a strong recovery adding more than 15%. Audinate (AD8) & Adore Beauty (ABY) both gained more than 14% in the week, but the star performer was St Barbara (SBM) which surged ~35%. The weakest positions were Aussie Broadband (ABB) falling...
Emerging Companies Portfolio
The portfolio was up +3.38% in the week, outpacing the performance of the small ords index. Cash in the portfolio is sitting at around 4%. Strong moves by PointsBet (PBH), Adore Beauty (ABY) & Pinnacle (PNI) all rallying over 13%. These gains were partially offset by ~10% falls in both EML Payments (EML) and Nitro Software (NTO) after poor updates. The small...
Emerging Companies Portfolio
The portfolio was up 4.94% in the week, ahead of the small ords index which rose 4%. Cash remains at around 4% with no changes to the portfolio. There was a wide spread of performance during the week as the EOFY washing machine of trades flowed through. Audinate (AD8) and Adore Beauty (ABY) rallied 16.9% and 13% respectively. Zip (ZIP) continued its poor run to fall -9.5%, and Tyro Payments (TYR) was also weak, down -8.2%.
Emerging Companies Portfolio
The portfolio was down -8.28% in the week, outpacing the 9.4% decline in the small ords – a tough week! Cash remains at around 4% with no changes to the portfolio. The weakness was driven by Calix (CXL) which fell -14.62%, while the biggest percentage fall was Zip Co (ZIP) down -18.32%, although it’s a very small weight in the portfolio. Adore Beauty (ABY) and Capitol Health (CAJ) were the outperformers this week.
Action
MM are selling ABY in the Emerging Companies Portfolio, taking a loss around $1.65
MM is neutral ABY – today’s result was weaker than we hoped
MM is bullish ABY
MM believes ABY is at or near a low around ~$1.35
MM remains patiently long ABY in our Emerging Companies Portfolio
MM is neutral ABY
MM is cautiously bullish ABY, looking for a push above $5.50
MM is holding ABY despite today’s downgrade
MM remains bullish ABY.
Business Summary
Adore Beauty Group Ltd is engaged in the online sales of cosmetics. It offers various products including skin care, hair care, body care, cosmetics, fragrances, oral care, and dietary supplements among others. The firm generates revenue through the sale of beauty and personal care products online. The Group has identified two distinct operating segments based on quantitative thresholds on profit or loss business, encompassing the Adore Beauty and iKOU brands.
James Gerrish discusses online retail in the wake of Googles results
Released Wednesday 28th April
Video
Relevant suggested news and content from the site
Video
Podcast
Video
Podcast
